title: [Experiences with biosimilar drugs in therapy].
abstract: Biosimilar drugs or drugs which are similar to reference biological drugs represent a new treatment option within the biological treatment. They are already the standard biotherapeutics option in some fields of medicine, in others as in diabetology, remain to be evaluated. The article presents the definition of biosimilar drugs and summarizes the therapeutic benefits and attitudes of agencies for drug control in the United States and Europe.
authors: Jaroslav
authors: J
authors: Škvor
mesh_terms: D059451:Biosimilar Pharmaceuticals; D004335:Drug and Narcotic Control; D005060:Europe; D006801:Humans; D014481:United States
chemical_list: D059451:Biosimilar Pharmaceuticals